Ian McDonald Files SC 13D on Bright Minds Biosciences Stock

Ticker: DRUG · Form: SC 13D · Filed: Jan 18, 2024 · CIK: 1827401

Complexity: simple

Sentiment: neutral

Topics: insider-ownership, shareholder-activism, ownership-change

TL;DR

**Ian McDonald just disclosed a major stake in Bright Minds Biosciences via a 13D.**

AI Summary

Ian McDonald, an individual, has filed an SC 13D on January 18, 2024, disclosing his ownership of common stock in BRIGHT MINDS BIOSCIENCES INC. The filing indicates that the event requiring this statement occurred on August 16, 2021. This matters to investors because a Schedule 13D filing signals a significant ownership stake, often exceeding 5%, which can indicate an activist investor or a substantial insider position, potentially influencing future company decisions or stock performance.

Why It Matters

This filing reveals a significant ownership position by Ian McDonald, which could signal potential influence over BRIGHT MINDS BIOSCIENCES INC.'s strategic direction or future corporate actions.

Risk Assessment

Risk Level: medium — The risk is medium because while a large stake can be positive, the specific intentions of the filer are not fully detailed in the provided excerpt, leaving uncertainty about potential future actions.

Analyst Insight

A smart investor would monitor future filings from Ian McDonald to understand his intentions (e.g., activist, passive, or divestment) and research BRIGHT MINDS BIOSCIENCES INC.'s recent performance and news to assess the potential impact of this significant ownership stake.

Key Players & Entities

FAQ

Who filed this SC 13D?

This SC 13D was filed by Ian McDonald, an individual, as indicated in the 'NAMES OF REPORTING PERSONS' section.

What company is the subject of this filing?

The subject company of this filing is BRIGHT MINDS BIOSCIENCES INC., as stated under 'Name of Issuer'.

What is the CUSIP number for the securities involved?

The CUSIP number for the common stock, without par value, is 10919W405, as listed in the filing.

When did the event requiring this filing occur?

The event which required the filing of this statement occurred on August 16, 2021, according to the filing.

What is the business address listed for BRIGHT MINDS BIOSCIENCES INC.?

The business address for BRIGHT MINDS BIOSCIENCES INC. is 19 Vestry Street, New York, NY 10013, as detailed in the 'BUSINESS ADDRESS' section.

Filing Stats: 1,521 words · 6 min read · ~5 pages · Grade level 14.6 · Accepted 2024-01-18 12:57:02

Filing Documents

Security and Issuer

Item 1. Security and Issuer This statement relates to the voting common stock, without par value, of Bright Minds Biosciences Inc., a British Columbia, Canada corporation (the " Issuer "). The Issuer maintains its principal executive office at 19 Vestry Street, New York, NY 10013.

Identity and Background

Item 2. Identity and Background Name: This statement is filed by Ian McDonald (the " Reporting Person "). Residence or Business Address: Mr. McDonald's address is: 560 King Street West Toronto, Ontario Canada, M5V 0L5 Present Principal Business or Occupation: Mr. McDonald's principal occupation is acting as the President, Chief Executive Officer and Director of the Issuer. Page 3 Place of Organization or Citizenship: Mr. McDonald is a Canadian citizen. Criminal Proceedings: During the last five years, the Reporting Person has not been convicted in any criminal proceeding. Civil Proceedings: During the last five years, the Reporting Person has not been a party to any civil proceeding of a judicial or administrative body of competent jurisdiction where, as a result of such proceeding, there was or is a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Source and Amount of Funds or Other Considerations

Item 3. Source and Amount of Funds or Other Considerations The Reporting Person is required to file a Schedule 13D with the Securities and Exchange Commission as a result of the Issuer becoming subject to the reporting obligations under the Act on August 16, 2021. As of August 16, 2021, the Reporting Person held 179,080 Common Shares of the Issuer's common stock after taking into account the Reverse Stock Split.

Purpose of Transaction

Item 4. Purpose of Transaction See Item 3 above. The Reporting Person reserves the right to formulate other plans or make other proposals and take other actions with respect to its interest in the Issuer. Depending on market conditions and other factors, the Reporting Person may acquire or dispose of securities of the Issuer as the Reporting Person may deem appropriate, whether in open market purchases or sales, privately negotiated transactions or otherwise. The Reporting Person continues to evaluate numerous potential transactions and in connection therewith may exchange Common Shares for other assets or may sell Common Shares to increase its cash position. The Reporting Person may also reconsider and change its plans or proposals relating to the foregoing. Except as otherwise disclosed herein, the Reporting Person has no current plans or proposals that relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) any extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of the assets of the Issuer or any of its subsidiaries; Page 4 (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure including, but not limited to, if the Issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by Section 13 of the United States Investment Company Act of 1940 ; (g) changes in the Issuer's charter, bylaws or instruments corresponding thereto or oth

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer The filing of this statement by the Reporting Person shall not be construed as an admission that the Reporting Person is, for the purposes of Section 13(d) or 13(g) of the Act, the beneficial owner of any securities covered by the statements herein. (a) For the purposes of this statement, the Reporting Person is reporting herein that, as of August 16, 2021, the Reporting Person was the beneficial owner of 179,080 Common Shares of the Issuer's common stock, representing approximately 7.57% of the Issuer's issued and outstanding common stock after taking into account the Reverse Stock Split. (b) For the purposes of this statement, the Reporting Person is reporting herein that, as of August 16, 2021, the Reporting Person had the sole power to vote or to direct the voting of, or to dispose or to direct the disposition of 179,080 Common Shares of the Issuer's common stock, representing approximately 7.57% of the Issuer's common stock after taking into account the Reverse Stock Split. (c) As of August 16, 2021, and within the sixty day period prior thereto, no transactions involving the Issuer's equity securities had been engaged in by the Reporting Person other than as disclosed herein. Page 5 (d) As of August 16, 2021, to the best knowledge and belief of the undersigned, except as otherwise reported herein, no person other than the Reporting Person had the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. (e) Not applicable.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer Except as disclosed herein, the Reporting Person does not have any contract, arrangement, understanding or relationship with respect to securities of the Issuer including, but not limited to, transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. The Reporting Person has not pledged securities of the Issuer nor are the securities of the Issuer held by the Reporting Person subject to a contingency, the occurrence of which would give another person voting power or investment power over such securities.

Material to Be Filed as Exhibits

Item 7. Material to Be Filed as Exhibits Not applicable. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 17, 2024. /s/ Ian McDonald Name: Ian McDonald __________

View Full Filing

View this SC 13D filing on SEC EDGAR

View on Read The Filing